176 related articles for article (PubMed ID: 21136060)
1. Evaluation of a non cystatin-C-based novel algorithm to calculate individual glomerular filtration rate in cancer patients receiving carboplatin.
Holweger K; Lipp HP; Beijnen JH; Bokemeyer C; Hartmann JT
Cancer Chemother Pharmacol; 2011 Sep; 68(3):693-701. PubMed ID: 21136060
[TBL] [Abstract][Full Text] [Related]
2. Novel algorithm for more accurate calculation of renal function in adults with cancer.
Holweger K; Lipp HP; Dietz K; Hartmann JT; Bokemeyer C
Ann Pharmacother; 2008 Dec; 42(12):1749-57. PubMed ID: 19033483
[TBL] [Abstract][Full Text] [Related]
3. Flat dosing of carboplatin is justified in adult patients with normal renal function.
Ekhart C; de Jonge ME; Huitema AD; Schellens JH; Rodenhuis S; Beijnen JH
Clin Cancer Res; 2006 Nov; 12(21):6502-8. PubMed ID: 17085665
[TBL] [Abstract][Full Text] [Related]
4. Difference of carboplatin clearance estimated by the Cockroft-Gault, Jelliffe, Modified-Jelliffe, Wright or Chatelut formula.
Nagao S; Fujiwara K; Imafuku N; Kagawa R; Kozuka Y; Oda T; Maehata K; Ishikawa H; Koike H; Aotani E; Kohno I
Gynecol Oncol; 2005 Nov; 99(2):327-33. PubMed ID: 16005943
[TBL] [Abstract][Full Text] [Related]
5. Prediction of carboplatin clearance calculated by patient characteristics or 24-hour creatinine clearance: a comparison of the performance of three formulae.
Okamoto H; Nagatomo A; Kunitoh H; Kunikane H; Watanabe K
Cancer Chemother Pharmacol; 1998; 42(4):307-12. PubMed ID: 9744776
[TBL] [Abstract][Full Text] [Related]
6. Carboplatin dosing in overweight and obese patients with normal renal function, does weight matter?
Ekhart C; Rodenhuis S; Schellens JH; Beijnen JH; Huitema AD
Cancer Chemother Pharmacol; 2009 Jun; 64(1):115-22. PubMed ID: 18989671
[TBL] [Abstract][Full Text] [Related]
7. A universal formula based on cystatin C to perform individual dosing of carboplatin in normal weight, underweight, and obese patients.
Schmitt A; Gladieff L; Lansiaux A; Bobin-Dubigeon C; Etienne-Grimaldi MC; Boisdron-Celle M; Serre-Debauvais F; Pinguet F; Floquet A; Billaud E; Le Guellec C; Penel N; Campone M; Largillier R; Capitain O; Fabbro M; Houede N; Medioni J; Bougnoux P; Lochon I; Chatelut E
Clin Cancer Res; 2009 May; 15(10):3633-9. PubMed ID: 19401344
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies.
de Lemos ML; Hsieh T; Hamata L; Levin A; Swenerton K; Djurdjev O; Vu T; Hu F; Conklin J; Malfair Taylor SC
Gynecol Oncol; 2006 Dec; 103(3):1063-9. PubMed ID: 16875719
[TBL] [Abstract][Full Text] [Related]
9. Prospective evaluation of carboplatin AUC dosing in patients with a BMI>or=27 or cachexia.
Herrington JD; Tran HT; Riggs MW
Cancer Chemother Pharmacol; 2006 Jan; 57(2):241-7. PubMed ID: 16133538
[TBL] [Abstract][Full Text] [Related]
10. Measured versus estimated glomerular filtration rate in the Calvert equation: influence on carboplatin dosing.
Donahue A; McCune JS; Faucette S; Gillenwater HH; Kowalski RJ; Socinski MA; Lindley C
Cancer Chemother Pharmacol; 2001 May; 47(5):373-9. PubMed ID: 11391850
[TBL] [Abstract][Full Text] [Related]
11. Estimation of glomerular filtration rate with creatinine-based versus cystatin C-based equations in kidney transplant recipients.
Savaj S; Shoushtarizadeh T; Abbasi MA; Razavimanesh SH; Ghods AJ
Iran J Kidney Dis; 2009 Oct; 3(4):234-8. PubMed ID: 19841528
[TBL] [Abstract][Full Text] [Related]
12. Simple cystatin C formula compared to sophisticated CKD-EPI formulas for estimation of glomerular filtration rate in the elderly.
Bevc S; Hojs R; Ekart R; Gorenjak M; Puklavec L
Ther Apher Dial; 2011 Jun; 15(3):261-8. PubMed ID: 21624073
[TBL] [Abstract][Full Text] [Related]
13. Extension of the Calvert formula to patients with severe renal insufficiency.
Oguri T; Shimokata T; Ito I; Yasuda Y; Sassa N; Nishiyama M; Hamada A; Hasegawa Y; Ando Y
Cancer Chemother Pharmacol; 2015 Jul; 76(1):53-9. PubMed ID: 25957958
[TBL] [Abstract][Full Text] [Related]
14. Estimation of glomerular filtration rate in cancer patients with abnormal body composition and relation with carboplatin toxicity.
Bretagne M; Jouinot A; Durand JP; Huillard O; Boudou Rouquette P; Tlemsani C; Arrondeau J; Sarfati G; Goldwasser F; Alexandre J
Cancer Chemother Pharmacol; 2017 Jul; 80(1):45-53. PubMed ID: 28508095
[TBL] [Abstract][Full Text] [Related]
15. Validation of a new plasma cystatin C-based formula and the Modification of Diet in Renal Disease creatinine-based formula for determination of glomerular filtration rate.
Sterner G; Björk J; Carlson J; Grubb A; Nyman U
Scand J Urol Nephrol; 2009; 43(3):242-9. PubMed ID: 19291590
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of various glomerular filtration rates estimating equations in patients with chronic kidney disease and diabetes.
Li HX; Xu GB; Wang XJ; Zhang XC; Yang JM
Chin Med J (Engl); 2010 Mar; 123(6):745-51. PubMed ID: 20368098
[TBL] [Abstract][Full Text] [Related]
17. A Comparison of GFR estimating formulae based upon s-cystatin C and s-creatinine and a combination of the two.
Tidman M; Sjöström P; Jones I
Nephrol Dial Transplant; 2008 Jan; 23(1):154-60. PubMed ID: 17911090
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Modified Diet in Renal Disease equation for calculation of carboplatin dose.
Shord SS; Bressler LR; Radhakrishnan L; Chen N; Villano JL
Ann Pharmacother; 2009 Feb; 43(2):235-41. PubMed ID: 19193580
[TBL] [Abstract][Full Text] [Related]
19. Performance of the creatinine-based and the cystatin C-based glomerular filtration rate (GFR) estimating equations in a heterogenous sample of patients referred for nuclear GFR testing.
Huang SH; Macnab JJ; Sontrop JM; Filler G; Gallo K; Lindsay RM; Clark WF
Transl Res; 2011 Jun; 157(6):357-67. PubMed ID: 21575920
[TBL] [Abstract][Full Text] [Related]
20. GFR prediction using the MDRD and Cockcroft and Gault equations in patients with end-stage renal disease.
Kuan Y; Hossain M; Surman J; El Nahas AM; Haylor J
Nephrol Dial Transplant; 2005 Nov; 20(11):2394-401. PubMed ID: 16115853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
